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Summary.-Human myeloma stem cells were detected by their capacity to form
colonies in culture. Cells separated from aspirated marrow were cultured for 10 days
in semi-solid methylcellulose with medium conditioned by T lymphocytes stimu-
lated by phytohaemagglutinin (PHA-TCM). The colonies formed consisted mostly
of lymphoplasmacytoid cells or plasma cells, and the immunoglobulins in the
patients' myeloma cells were demonstrated also in the cytoplasm of the colony
cells. The number of colonies were proportional to the number of cells plated and
to the concentration of PHA-TCM. When the proportion of proliferating colony-
forming units of multiple myeloma (CFU-MM) was studied using the (3H)-dT-suicide
technique, the high-specific-activity (3H)-dT killed 21-45% of the CFU-MM in 7
myeloma patients. According to a single dose of 60Co-y-irradiation, the mean doses
for impairment of regeneration (Do) were 1-00 and 1.63 Gy in 2 cases, the extra-
polation numbers being 1.6 and 2.0.
IT IS BELIEVED thatprecise characteriza-
tion of tumour stem cells and their
quantitation are necessary for a better
understanding of the basic cell-renewal
system of tumours and of their response
to therapy. Recently, colony assays of
patientswith multiple myeloma (MM) have
shown that their marrows contain pro-
genitor cells capable of forming colonies
containing plasma cells and lymphoblasts.
Thus the myeloma colony assay seems to
permit qualitative and quantitative studies
of human myeloma stem cells. In order
to study the kinetics of myeloma stem
cells and their sensitivity to radiation, we
used the myeloma colony assay and
estimated the fractions of proliferating
myeloma stem cells in the DNA-synthesis
(S) phase ofthe cell cycle, and the response
of these cells to single-dose y-irradiation.
The results of this study are reported
here.
MATERIALS AND METHODS
Patients.-Nine patients with well docu-
mented multiple myeloma (MM) were selected
for the study. Their clinical status is detailed
in Table I.
Immunoelectrophoretic studies of the sera
revealed that 7 patients had IgGK, 1 IgGA,
and 1 IgAA type myeloma. Six patients were
new cases and 3 were in relapse after treat-
ment by intermittent administration of
melphalan and prednisolone. Marrow samples
for in vitro studies on these 3 patients were
obtained 3-4 weeks after the previous
course of therapy.
Cell collection.-Marrow cells were obtained
in heparinized syringes by puncture of the
sternum or posterior iliac crest, and were
suspended in a-MEM (Gibco). Mononuclear
cells were separated from the suspension of
marrow cells by centrifugation through a
Ficoll-Conray (Conray 400: Sodium iotala-
mate) gradient at a density of 1 077. The
mononuclear cell fraction from our 9 patients
contained 85-95% myeloma cells. These
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cells were washed x 3 in o-MEM and sus-
pended in a-MEM with 10% foetal calf
serum (FCS) (Flow Lab.).
Culture method.-Culture methods for
myeloma colony formation described by
Izaguirre et al. (1980) were used, with minor
modifications.
T-lymphocyte-conditioned medium (PHA-
TCM) was prepared by incubating T lympho-
cytes with 1% PHA (Wellcome, H-15) in
a-MEM and 10% FCS at 37°C for 3 days. The
supernatants were collected, filter-sterilized,
and stored before use. To obtain T lympho-
cytes, peripheral mononuclear cells from a
normal volunteer, that had formed SRBC
rosettes, were treated with NH4Cl-tris buffer,
washed and resuspended in a-MEM with 10%
FCS. Cells from the myeloma-cell-enriched
fractions were prepared in concentrations
from 1 to 5 x 105 cells/ml in the presence of
0.8% methylcellulose, 20% FCS, and 20%
PHA-TCM. After mixing each suspension
with a vortex mixer, a lml aliquot of the
mixture was plated in a culture dish (35x
10 mm, Falcon Plastics). The culture was then
incubated at 37°C in 5% CO2 in air at 100%
humidity for 10 days. At least 4 replicates
were prepared for each experiment.
Characterization of proliferating cells.-At
the termination of culture, the number of
colonies containing 20 or more cells were
counted with an inverted microscope. Indi-
vidual colonies were picked using finely
drawn Pasteur pipettes and suspended in
phosphate-buffered saline (PBS). Cells from
single colonies were spun on glass slides,
using a Shandon cytocentrifuge. The cells
from individual colonies were assessed for
morphology, using May-Giemsa, myelo-
peroxidase, and PAS. For the determination
of cytoplasmic immunoglobulin (clg), cells
pooled from 50-100 colonies were washed in
PBS with 2% bovine serum albumin and
0.2% sodium azide and stained using mono-
specific FITC-labelled antisera (anti-human-
IgA, anti-human-IgG, anti-human-K, anti-
human-A; Behring). Cells from individual
colonies were also tested for rosette formation
with SRBC.
Determination of the percentage of cell in
S phase by [3H]-dT killing.-The [3H]-dT-
suicide method of Iscove (1977) was used to
measure the proportion of colony-forming
units of multiple myeloma (CFU-MM).
Briefly, the cells from the myeloma-cell-
enriched fractions of 7 patients were exposed
to [3H]-dT as follows: 1 ml of the cell sus-
pensions was placed in lOml centrifuge tubes
containing a solution of [3H]-dT (methyl-T-
thymidine, 73-6 Ci/mmol) made up in Hanks'
balanced salt solution without thymidine
(HBSS) (Flow Lab.). The tubes were then
incubated with occasional agitation in a water
bath at 37°C. After 20min incubation,
uptake of [3H]-dT was halted by adding
lOml of ice-cold HBSS containing 100 jug/ml
of cold dT and 10% FCS. The cells were
then washed x 3 with unlabelled HBSS con-
taining dT and FCS, and cultured for CFU-
MM.
Radiation sensitivity of CFU-MM.-The
myeloma-cell-enriched fractions (cases 7 and
9) in ax-MEM with 10% FCS, were exposed to
0-5-2 Gy of60Co y-ray (doserate 1V29 Gy/min)
and culture for CFU-MM was started 3 h after
irradiation.
TABLE I.-Clinical data and number ofmyeloma colonies
Colony formation
No. per
Case Myeloma Therapy 4 x 105 cells
No. Sex Age type until testing (± s.d.) cIg
1 F 64 GK None 909 + 23 Gnd
2 F 69 AA M.P. 351+15 And
3 Al 70 GK M.P. (a) 209+ 14* GK (b)662+49
4 F 50 GK None 354 + 33 GK
5 M 56 GK M.P. 473 + 37 GK
6 F 54 GK None 2022 + 129 GK
7 F 82 GK None 1135+ 69 GK
8 F 64 GK None 564+ 26 GK
9 M 57 GA None 1858+ 81 GA
nd not done, M-Melphalan, P-Prednisolone.
* Marrow specimens were taken immediately after MP treatment.




FIG. 1. Characterization of myeloma cells. (a) A typical myeloma colony from a 10-day-old culture
( x 200). (b) Part of a myeloma colony stained withl immunofluorescence. Cells -were fixe(d in etlhanol
an(l stained (lirectly with fluorescent anti-human IgG. Note the specific cytoplasmic fluorescence.
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FiG. 2.-Relationship between cell number
plated and colony formation. Eacbi point
is the mean of 4 replicates + s.d.
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Fi(m. 3. Dose-response curve to PHA-TCMT in
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RESULTS
Myeloma cell colony formation was
determined in 10 marrow preparations
from 9 patients with MM. The number of
colonies on Day 10 varied from 209 to
2022 per 2 x 105 inoculated cells (Table I).
The number ofcolonies per plate increased
until Day 10 and decreased thereafter
(data not shown).
TABLE II.-Effect of [3H]-dT on the
colony-forming ability of human myeloma




% survival of CFU-MM
A_
Case cells 100 ftCi/ 20 ,uCi/
No. (±s.d.) 20 ,&Ci/ml ml ml+dTt
2 351+15 71+ 7 55+4 107 + 7
3b 662+49 65+7 64+8 103+7
4 354+33 66+9 58+10 93+5
5 437+37 78+8 79+7 103+7
7 1135+69 61+4 59+6 95+5
8 564+26 75+5 77+8 104+3
9 1858+81 74 +-4 67+4 101+4
Mean 70 66 101
* Exposed to 73-6 Ci/mmol of [3H]-dT in vitro
for 20 min.
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FIG. 4.-The effect of y-irradiation on
CFU-MM using 60Co y-rays in Cases 7
(O) and 9 (0).
The cells within the colonies looked
like lymphoplasmacytoid or plasmacytoid
cells, as seen in Wright-Giemsa prepara-
tions (Fig. 1). These cells were negative
both for myeloperoxidase and PAS. More-
over, more than 95% of them did not
form SRBC rosettes.
Immunoglobulin classes were deter-
mined in the cells initially plated and in
the cells from colonies (Table I). It is
apparent that the same Ig class was
found in the original cells and in the cells
from the colonies (Table I and Fig. 1),
indicating that the cells in the colonies
were derived from MM cells.
The relationship between the number
of cells initially plated and that of
colonies formed was linear, with extra-
polation through the origin (Fig. 2).
This is an evidence that the culture
conditions are indeed adequate for quanti-
tation of CFU-MM. A linear relationship
was also observed between PHA-TCM
concentrations of up to 30% and the
number of colonies formed (Fig. 3,
Case 9). In other cases, however; the
number of colonies reached a plateau at
20% of PHA-TCM.
Suicide assay with [3H]-dT
As shown in Table II, 55-80% of the
CFU-MM survived the 20 min exposure
to [3H]-dT at both the 20 and 100 /Ci/ml
concentrations. The effect of the radio-
isotope was successfully blocked by the
simultaneous addition of excess cold
dT, showing that detectable inactivation
of CFU-MM was the result of 20 min
exposure to [3H]-dT.
Radiosensitivity
The results of y-ray irradiation to
CFU-MM in 2 cases are shown in Fig. 4.
In both cases, colony formation was
suppressed exponentially by y-irradiation.
The Do estimated from the linear re-
gression ofthe curves are 1 00 and 1 63 Gy,
and extrapolation numbers are 1-6 and
2-0 respectively.
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DISCUSSION
Using the modified method developed
by Izaguirre et al. (1980) human myeloma
stem cells could be detected by their
ability to form colonies. When 4 x 105
cells of the 10 marrow preparations of
9 patients were plated, a sufficiently
high plating efficiency (0-15-1.0%) was
obtained to allow a reliable comparison
between test and control assays. This
plating efficiency is similar to that
reported by Izaguirre et al. (1980) but
much higher than that reported by
Hamburger and Salmon (1977).
The proportion of CFU-MM killed by
pulse labelling with high-specific-activity
[3H]-dT was 21-45%, which corresponds
to that ofCFU-C (Cronkite & Feinendegen,
1976). Thus it could be considered that
myeloma stem cells have similar prolifer-
ative characteristics to CFU-C, but higher
than pluripotent stem cells (Fauser &
Messner, 1979).
On the other hands, it was reported
that 5000 or more leukaemic stem cells
are in cell cycle (Minden et al., 1979).
These differences between CFU-MM and
leukaemic stem cells may require different
treatments for these diseases. Thus phase-
specific drugs such as cytosine arabi-
noside or methotrexate are often useful
for the treatment of acute leukaemia, but
not for multiple myeloma.
It has been reported by Hamburger &
Salmon (1977) that no [3H]-dT suicide
of CFU-MM occurred in 2 patients out
of 7, and > 60% of CFU-MM were killed
in 4 patients. We have not encountered
such stable or such highly proliferative
cases so far. The differences between their
data and ours may be due to a difference
in patients' conditions, or to the method-
ology ofdetecting CFU-MM.
As shown in Fig. 4, D0 of CFU-MM
in 2 cases was 1.00 and 1P63 Gy. These
values are the same as for human pluri-
potent stem cells and granulocyte-macro-
phage colony-forming units. The radiation
sensitivity of CFU-MM, in Case 9, how-
ever, might be higher than this, as the
concentration of PHA-TCM was sub-
optimal.
These results give some insight into
the kinetics and behaviour of human
myeloma stem cells, possibly contributing
to an improvement in therapy.
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